Renalytix Plc

0.00 (0.0%)

Renalytix Financial Summary

The current RENX market cap is 65.53M. The company's latest EPS is -75.9 and P/E is -1.15.

Year End 30 June 2019202020212022
Total Revenue 0339k1.49M2.97M
Operating Income -6.96M-10.8M-34.72M-57.24M
Net Income -5.98M-9.25M-31.01M-56.73M
Year End 30 June 2019202020212022
Total Assets 28.92M41.3M102.58M63.26M
Total Liabilities 755k5.34M7.48M20.09M
Total Equity 28.17M35.96M95.1M43.17M
Year End 30 June 2019202020212022
Operating -4.42M-10.06M-24.63M-45.75M
Investing -13.05M-849k-741k-694k
Financing 26.74M16.85M77.24M25.52M
Market Cap 65.53M
Price to Earnings Ratio -1.15
Price to Sales Ratio 21.88
Price to Cash Ratio 1.59
Price to Book Ratio 1.52
Dividend Yield -

Share Statistics

Shares Outstanding 74.89M
Average Volume (1 week) 73.44k
Average Volume (1 Month) 46.13k
52 Week Change -46.15%
52 Week High 190.00
52 Week Low 47.50
Spread (Intraday) 5 (5.56%)

Company Info

Company Name Renalytix Plc
Address finsgate
london EC1V 9EE
Industry services, nec (8999)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230607 23:38:23